Showing results (21-30 of 55) with videos related to
Sort By:
Pageof 6
Haematologica|August 28, 2025
Benchmarking prophylaxis with factor concentrates: reference data on annualized bleeding rates in children with severe hemophiliaSusanna Ranta, Marloes De Kovel, Martin Olivieri, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|September 3, 2025
Health-Related Quality of Life, Physical Activity and Joint Health in People With Severe Haemophilia A Receiving Emicizumab: Results From the Phase IV HemiNorth 2 StudyJan Astermark, Susanna Ranta, Linda Myrin-Westesson, et al.Pediatric Blood & Cancer|November 2, 2019
The spectrum of acute central nervous system symptoms during the treatment of childhood acute lymphoblastic leukaemiaJoanna Banerjee, Riitta Niinimäki, Päivi Lähteenmäki, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|May 30, 2025
Impact of Family History of Haemophilia on Diagnosis, Management and Outcomes in Severe HaemophiliaAna Mendoza, Isabel Rivas, Olga Benítez Hidalgo, et al.Pediatric Blood & Cancer|November 20, 2025
Early Toxicity in Childhood Acute Lymphoblastic Leukemia: A Comparison of NOPHO ALL2008 and ALLTogether Protocols in SwedenJohannes Fermér, Hannah van Bunningen, Otto Zhou, et al.Thrombosis and Haemostasis|July 26, 2023
Clinical Implications of Discrepancy between One-Stage Clotting and Chromogenic Factor IX Activity in Hemophilia BDavid E Schmidt, Åsa Truedsson, Annelie Strålfors, et al.European Journal of Haematology|August 25, 2022
Changes in body mass index during treatment of childhood acute lymphoblastic leukemia with the Nordic ALL2008 protocolChristina Egnell, Hanna Närhinen, Andrea Merker, et al.Acta Oncologica (Stockholm, Sweden)|September 19, 2023
Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemiaChristina Egnell, Helene Hallböök, Mats Heyman, et al.Thrombosis Research|July 17, 2022
Factor IX antibodies and tolerance in hemophilia B in the Nordic countries - The impact of F9 variants and complicationsKristina Kihlberg, Fariba Baghaei, Maria Bruzelius, et al.British Journal of Haematology|November 2, 2021
Obesity as a predictor of treatment-related toxicity in children with acute lymphoblastic leukaemiaChristina Egnell, Mats Heyman, Ólafur Gisli Jónsson, et al.Pageof 6